The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death.
Open accessAbstract
Expression of the bcl-2 gene has been shown to effectively confer resistance to programmed cell death under a variety of circumstances. However, despite a wealth of literature describing this phenomenon, very little is known about the mechanism of resistance. In the experiments described here, we show that bcl-2 gene expression can result in an inhibition of cell division cycle progression. These findings are based upon the analysis of cell cycle distribution, cell cycle kinetics, and relative phosphorylation of the retinoblastoma tumor suppressor protein, using primary tissues in vivo, ex vivo, and in vitro, as well as continuous cell lines. The effects of bcl-2 expression on cell cycle progression appear to be focused at the G1 to S phase transition, which is a critical control point in the decision between continued cell cycle progression or the induction programmed cell death. In all systems tested, bcl-2 expression resulted in a substantial 30-60% increase in the length of G1 phase; such an increase is very substantial in the context of other regulators of cell cycle progression. Based upon our findings, and the related findings of others, we propose a mechanism by which bcl-2 expression might exert its well known inhibition of programmed cell death by regulating the kinetics of cell cycle progression at a critical control point.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 2×
“instance, p53 expression is stabilized by D N A damage, and p53 has been shown to be a positive regulator o f bax transcription (15).”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Involvement of the bcl -2 Gene in Human Follicular Lymphoma
Tsujimoto, Y., Cossman, J., Jaffe, E., & Croce, C. M. (1985) · Science · doi:10.1126/science.3874430 · Cited by 1,786
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., & Korsmeyer, S. J. (1991) · Cell · doi:10.1016/0092-8674(91)90361-2 · Cited by 1,194
Karasuyama, H., & Melchers, F. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180115 · Cited by 1,065
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
Strasser, A., Harris, A. W., & Cory, S. (1991) · Cell · doi:10.1016/0092-8674(91)90362-3 · Cited by 1,054
Apoptotic cell death induced by c-myc is inhibited by bcl-2
Bissonnette, R. P., Echeverri, F., Mahboubi, A., & Green, D. R. (1992) · Nature · doi:10.1038/359552a0 · Cited by 957
Turnover of naive- and memory-phenotype T cells.
Tough, D. F., & Sprent, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1127 · Cited by 869 · cited 1×
“No adverse affects of this treatment (e.g., weight loss or thymic atrophy) have been observed, in agreement with the published findings of others ( 21 ).”
ResultCheckpoints of dueling dimers foil death wishes
Oltvai, Z. (1994) · Cell · doi:10.1016/0092-8674(94)90188-0 · Cited by 795
Cooperative interaction between c-myc and bcl-2 proto-oncogenes
Fanidi, A., Harrington, E. A., & Evan, G. I. (1992) · Nature · doi:10.1038/359554a0 · Cited by 759
Kowalik, T. F., DeGregori, J., Schwarz, J. K., & Nevins, J. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2491-2500.1995 · Cited by 418
Miyazaki, T., Liu, Z.-J., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E. L., Perlmutter, R. M., & Taniguchi, T. (1995) · Cell · doi:10.1016/0092-8674(95)90332-1 · Cited by 362
Activation of cyclin A-dependent protein kinases during apoptosis.
Meikrantz, W., Gisselbrecht, S., Tam, S. W., & Schlegel, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3754 · Cited by 345
Akbar, A. N., Borthwick, N., Salmon, M., Gombert, W., Bofill, M., Shamsadeen, N., Pilling, D., Pett, S., Grundy, J. E., & Janossy, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.427 · Cited by 336
The generation and fate of thymocytes.
Shortman, K., Egerton, M., Spangrude, G. J., & Scollay, R. G. (1990) · PubMed · Cited by 295
Inhibition of apoptosis by the retinoblastoma gene product.
Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., T'Ang, A., Fung, Y. K., & Israel, M. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07022.x · Cited by 281
Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.
Kato, J. Y., & Sherr, C. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11513 · Cited by 220
Dedera, D. A., Waller, E. K., LeBrun, D. P., Sen-Majumdar, A., Stevens, M. E., Barsh, G. S., & Cleary, M. L. (1993) · Cell · doi:10.1016/0092-8674(93)90463-z · Cited by 189
Petrie, H. T., Livak, F., Burtrum, D., & Mazel, S. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.121 · Cited by 176
Self-citationRubin, L. L., Philpott, K. L., & Brooks, S. F. (1993) · Current Biology · doi:10.1016/0960-9822(93)90211-6 · Cited by 132
Petrie, H. T., Hugo, P., Scollay, R. G., & Shortman, K. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.6.1583 · Cited by 132
Self-citationControl of fibroblast senescence and activation of programmed cell death
Wang, E., Lee, M., & Pandey, S. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240540410 · Cited by 78
Cited by
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
BCL-2 FAMILY: Regulators of Cell Death
Chao, D. T., & Korsmeyer, S. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.395 · Cited by 1,685
The Bcl-2 family: roles in cell survival and oncogenesis
Cory, S., Huang, D. C. S., & Adams, J. M. (2003) · Oncogene · doi:10.1038/sj.onc.1207102 · Cited by 1,463
Yamamoto, K., Ichijo, H., & Korsmeyer, S. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8469 · Cited by 1,003
Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria
Wang, H.-G., Rapp, U. R., & Reed, J. C. (1996) · Cell · doi:10.1016/s0092-8674(00)81383-5 · Cited by 766
Metadata
- Authors
- Mazel, S., Burtrum, D., & Petrie, H. T.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-05-01
- Volume
- 183
- Issue
- 5
- Pages
- 2219-2226
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2162522735
- Cited by
- 270
- References
- 26
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.